PMC:3897848 / 1656-2811 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3897848","sourcedb":"PMC","sourceid":"3897848","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3897848","text":"Introduction\nBiobanks provide important materials for many research realms, such as biomarker development for the early diagnoses of specific diseases, including cancer and genetic diseases, and for applying personalized drug therapies. There is no consensus definition for a biobank, but it is considered a biorepository that stores biospecimens for use for diagnostic or research purposes. Also, a biobank is an institution that collects, stores, processes, and uses biological materials, genetic data, and associated epidemiological data from human beings or distributes them to researchers [1]. The term \"research biobank\" means a collection of human biological material and data obtained directly by the analysis of this material, which is used or is to be used for research purposes [2]. A repository is defined as an organization, place, room, or physical entity that may receive, process, store, maintain, and/or distribute specimens, their derivatives, and their associated data. In this paper, we provide a review of biobanks, including Korean biobanks and an analysis of sample volumes, regulations, policies, and ethical issues of the biobank.","divisions":[{"label":"Title","span":{"begin":0,"end":12}}],"tracks":[]}